On March 16, 2021, Solid Biosciences joined PPMD for a webinar to provide a safety and efficacy update on the ongoing IGNITE DMD phase I/II clinical study of SGT-001 microdystrophin gene therapy in patients with Duchenne muscular dystrophy. Research & Clinical Trial Webinars,Webinars 4 years ago You may also like 56:20 Domagrozumab as a Potential Treatment for Duchenne (May 2019) 5 years ago Research & Clinical Trial Webinars,Webinars 55:59 Santhera Update to the Duchenne Community (May 2019) 6 years ago Research & Clinical Trial Webinars,Webinars 34:57 Capricor’s Clinical Program (April 2019) 6 years ago Research & Clinical Trial Webinars,Webinars 48:55 Italfarmaco Provides Givinostat Update (March 2019) 6 years ago Research & Clinical Trial Webinars,Webinars 1:00:47 Caring for the Caregiver (February 2019) 6 years ago Care Webinars,Webinars 59:40 Vamorolone Clinical Trials in Duchenne (January 2019) 6 years ago Research & Clinical Trial Webinars,Webinars 44:17 Translarna® (ataluren) Development Update (January 2019) 6 years ago Research & Clinical Trial Webinars,Webinars 1:04:43 The Heart of the Matter – PPMD’s Research Priorities (December 2018) 6 years ago Research & Clinical Trial Webinars,Webinars «1…1314151617…25»Page 15 of 25
by: Parent Project Muscular Dystrophy
